Centre-Val de Loire And NotFatima Albizuri
List of bibliographic references
Number of relevant bibliographic references: 16.| Ident. | Authors (with country if any) | Title |
|---|---|---|
| 000411 | Lutz Wollin [Allemagne] ; Dieudonnée Togbe [France] ; Bernhard Ryffel [France] | Effects of Nintedanib in an Animal Model of Liver Fibrosis |
| 001086 | X. Grimaux [France] ; S. Leducq [France] ; P. Goupille [France] ; A. Aubourg [France] ; E. Miquelestorena-Standley [France] ; M. Samimi [France] | [Aphthous mouth ulcers as an initial manifestation of sécukinumab-induced inflammatory bowel disease]. |
| 001719 | Erwin Dreesen ; Peter Bossuyt [Belgique] ; Denis Mulleman [France] ; Ann Gils ; Dora Pascual-Salcedo [Espagne] | Practical recommendations for the use of therapeutic drug monitoring of biopharmaceuticals in inflammatory diseases |
| 001836 | Amélie Moreau [France] ; Marc Le Vée [France] ; Elodie Jouan [France] ; Claire Denizot [France] ; Yannick Parmentier [France] ; Olivier Fardel [France] | Effect of Gevokizumab on Interleukin-1β-Mediated Cytochrome P450 3A4 and Drug Transporter Repression in Cultured Human Hepatocytes. |
| 002090 | David Ternant [France] ; Theodora Bejan-Angoulvant [France] ; Christophe Passot [France] ; Denis Mulleman [France] ; Gilles Paintaud [France] | Clinical Pharmacokinetics and Pharmacodynamics of Monoclonal Antibodies Approved to Treat Rheumatoid Arthritis. |
| 002595 | C. Chabbert [France] ; H. Adamski [France] ; G. Guillet [France] ; B. Sassolas [France] ; L. Misery [France] ; A. Perrinaud [France] ; L. Machet [France] ; G. Quereux [France] ; E. Esteve [France] ; E. Solau-Gervais [France] ; A. Saraux [France] ; E. Polard [France] ; T. Lesimple [France] ; F. Le Gall [France] ; B. Dreno [France] ; A. Dupuy [France] | Cutaneous melanoma in patients treated with tumour necrosis factor inhibitors: a retrospective series of 15 patients |
| 002648 | M. Samimi [France] ; F. Lauferon ; B. Hüttenberger ; L. Vaillant ; P. Goupille ; L. Machet | [Persistent aphthous mouth ulcers associated with tocilizumab: two cases]. |
| 002735 | A. Woerner [Suisse, France] ; F. Uettwiller [France] ; I. Melki [France] ; B. Bader-Meunier [France] ; R. Mouy [France] ; C. Wouters [France] ; P. Quartier [France] | PReS-FINAL-2133: Drug survival and switching of biological agents in systemic juvenile idiopathic arthritis |
| 002B79 | J. Mélet ; D. Mulleman ; P. Goupille ; B. Ribourtout [France] ; H. Watier [France] ; G. Thibault [France] | SAT0102 Rituximab-Induced T-Cell Depletion in Patients with Rheumatoid Arthritis: Association With Clinical Response |
| 003373 | M. Samimi [France] ; F. Lauferon [France] ; B. Hüttenberger [France] ; L. Vaillant [France] ; P. Goupille [France] ; L. Machet [France] | Ulcérations buccales aphtoïdes persistantes associées au tocilizumab: deux cas |
| 003496 | Fernando Kemta Lekpa [France] ; Cécile Poulain [France] ; Daniel Wendling [France] ; Martin Soubrier [France] ; Michel De Bandt [France] ; Jean Marie Berthelot [France] ; Philippe Gaudin [France] ; Eric Toussirot [France] ; Philippe Goupille [France] ; Thao Pham [France] ; Jérémie Sellam [France] ; Rémy Bruckert [France] ; Muriel Paul [France] ; Valérie Farrenq [France] ; Pascal Claudepierre [France] | Is IL-6 an appropriate target to treat spondyloarthritis patients refractory to anti-TNF therapy? a multicentre retrospective observational study |
| 003560 | J E Gottenberg [France] ; P. Ravaud [France] ; A. Cantagrel [France] ; B. Combe [France] ; R M Flipo [France] ; T. Schaeverbeke [France] ; E. Houvenagel [France] ; P. Gaudin [France] ; D. Loeuille [France] ; S. Rist [France] ; M. Dougados [France] ; J. Sibilia [France] ; X. Le Loët [France] ; C. Marcelli [France] ; T. Bardin [France] ; I. Pane [France] ; G. Baron [France] ; X. Mariette [France] | Positivity for anti-cyclic citrullinated peptide is associated with a better response to abatacept: data from the ‘Orencia and Rheumatoid Arthritis’ registry |
| 003587 | Gilles Paintaud [France] ; Marine Diviné [France] ; Philippe Lechat [France] | Anticorps monoclonaux à usage thérapeutique : spécificités du développement clinique, évaluation par les agences, suivi de la tolérance à long terme |
| 003664 | Gilles Paintaud [France] ; Marine Diviné [France] ; Philippe Lechat [France] | Monoclonal Antibodies for Therapeutic Use: Specific Characteristics of Clinical Development, Evaluation by the Agencies, and Long-term Monitoring of Safety |
| 003C00 | Thao Pham ; Pascal Claudepierre [France] ; Arnaud Constantin ; Michel De Bandt ; Bruno Fautrel [France] ; Laure Gossec [France] ; Jacques-Eric Gottenberg ; Philippe Goupille [France] ; Severine Guillaume [France] ; Eric Hachulla [France] ; Charles Masson ; Jacques Morel [France] ; Xavier Puechal ; Alain Saraux ; Thierry Schaeverbeke [France] ; Daniel Wendling ; Eric Bruckert [France] ; Stanislas Pol [France] ; Xavier Mariette [France] ; Jean Sibilia | Tocilizumab therapy and safety management |
| 003E58 | G. Moutarde [France] ; P. Le Blay [France] ; T. Barnetche [France] ; P. Goupille [France] | Le risque de néoplasie solide au cours de la polyarthrite rhumatoïde: impact des biothérapies |
| This area was generated with Dilib version V0.6.34. |  |